510(k) device
MiniMed 780G Insulin Pump (MMT-1884)
Medtronic Minimed, Inc. · Alternate Controller Enabled Insulin Infusion Pump (QFG, Class II) · First FDA decision Jul 1, 2025, newest Jan 15, 2026Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
36
Naming "MiniMed 780G"
MAUDE reports
207,191
Brand "MiniMed 780G", since 2015
PubMed studies
265
Mentioning "MiniMed 780G"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MiniMed 780G Insulin Pump (MMT-1884)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K253470 · Decided Jan 15, 2026 · 97 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K251032 · Decided Jul 1, 2025 · 89 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Insulin Infusion PumpNational analysisReview closedCAG-00041NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "MiniMed 780G", any status and sponsor, newest update first.
University of Colorado, DenverAcademic, hospital or other
NCT07720388 · 15 participants (planned) · Start Oct 2, 2026 · Primary completion Jul 2027
Device: Medtronic MiniMed 780G Insulin Pump System · For: Diabetes Mellitus, Type 1 Diabetes
Sites: Aurora, Colorado
- Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)Pivotal-lookingRecruiting
Medtronic MiniMed, Inc.Public (MDT)
NCT07227805 · 116 participants (planned) · Start Jul 19, 2026 · Primary completion Mar 17, 2027
Device: NMX8; 780G · For: Diabetes (Insulin-requiring, Type 1 or Type 2)
Sites: Antwerp, Belgium; Brussels, Belgium; Leuven, Belgium · 9 sites in all
Sheba Medical CenterGovernment (non-federal)
NCT06236256 · 42 participants · Start Jan 9, 2024 · Primary completion Aug 20, 2025
Device: MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system · For: Diabetes Mellitus, Type 1
Sites: Ramat Gan, Israel
33 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MiniMed 780G", and for the whole product code for context.
This brand
207,191 reports: 176,451 malfunction, 30,573 injury, 160 death
Whole product code QFG
1,370,384 reports: 1,216,047 malfunction, 153,806 injury, 383 death
Newest reports for this brand
Medtronic Puerto Rico Operations Co.
2032227-2026-264260 · Received Oct 30, 2026 · Event dated Oct 21, 2026
Device type: Automated Insulin Dosing Device System, Single Hormonal Control (OZP)
Device problem as coded: Key or Button Unresponsive/not Working
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-264265 · Received Oct 30, 2026 · Event dated Oct 23, 2026
Device type: Automated Insulin Dosing Device System, Single Hormonal Control (OZP)
Device problem as coded: Date/Time-Related Software Problem; Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-264266 · Received Oct 30, 2026 · Event dated Oct 22, 2026
Device type: Automated Insulin Dosing Device System, Single Hormonal Control (OZP)
Device problem as coded: Obstruction of Flow
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;Open, Classified
Z-2980-2026 · Started Jul 13, 2026 · Posted by FDA Aug 18, 2026
Reason given: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis.
Cause as FDA categorized it: Process design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
- MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLWOpen, Classified
Z-2982-2026 · Started Jul 13, 2026 · Posted by FDA Aug 18, 2026
Reason given: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis.
Cause as FDA categorized it: Process design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Z-2698-2026 · Started May 27, 2026 · Posted by FDA Jul 8, 2026
Reason given: A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and...
Cause as FDA categorized it: Software design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
3 more recall records with a free account
Published research
The most relevant PubMed records for "MiniMed 780G"[tiab]. The summary above synthesizes these.
- Editorial: Technologies for diabetes.
Salzano G, Tinti D, Cardona-Hernandez R, et al. · Front Endocrinol (Lausanne) · 2023Editorial
- MiniMed 780Gࡊ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks.
Pulkkinen MA, Varimo TJ, Hakonen ET, et al. · Diabetes Technol Ther · 2023Clinical Trial, Research Support, Non-U.S. Gov't
- Exercising Safely with the MiniMedࡊ 780G Automated Insulin Delivery System.
O'Neal DN, Zaharieva DP, Morrison D, et al. · Diabetes Technol Ther · 2024
- MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control.
Lombardo F, Passanisi S, Alibrandi A, et al. · Diabetes Technol Ther · 2023Multicenter Study, Observational Study
- Comparison of MiniMed 780G system performance in users aged younger and older than 15ߙyears: Evidence from 12ߙ870 real-world users.
Arrieta A, Battelino T, Scaramuzza AE, et al. · Diabetes Obes Metab · 2022Research Support, Non-U.S. Gov't
- Performance of the MiniMed 780G system on mitigating menstrual cycle-dependent glycaemic variability.
Elhenawy YI, Abdel Kader MS, Thabet RA · Diabetes Obes Metab · 2024
- Does minimed 780GTM insulin pump system affect energy and nutrient intake?: long-term follow-up study.
Atik-Altinok Y, Mansuroglu Y, Demir G, et al. · Eur J Clin Nutr · 2024
- MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience.
Rachmiel M, Lebenthal Y, Mazor-Aronovitch K, et al. · Diabetes Technol Ther · 2023Observational Study, Multicenter Study
- Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus.
Pintaudi B, Gironi I, Nicosia R, et al. · Nutr Metab Cardiovasc Dis · 2022
- Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis.
Di Molfetta S, Di Gioia L, Caruso I, et al. · Diabetes Metab Res Rev · 2024Systematic Review, Network Meta-Analysis
- Real-world efficacy of MiniMedࡊ780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes.
Bassi M, Spacco G, Pezzotta F, et al. · Front Endocrinol (Lausanne) · 2025
- MiniMed 780Gࡊ advanced hybrid closed-loop system performance in Egyptian patients with type 1 diabetes across different age groups: evidence from real-world users.
Elbarbary NS, Ismail EAR · Diabetol Metab Syndr · 2023
Other devices of this type
Also filed under product code QFG.
- Tandem Mobi insulin pump with interoperable technologyTandem Diabetes Care, Inc. · 510(k) 2025
- t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc. · De Novo 2025
- iLet ACE PumpBeta Bionics, Inc. · 510(k) 2026
- DEKA ACE Pump SystemDeka Research and Development · 510(k) 2024
- Mint ACE PumpBeta Bionics, Inc. · 510(k) 2026
- Omnipod 5 ACE PumpInsulet Corporation · 510(k) 2023
- twiist Automated Insulin Delivery (AID) SystemDeka Research and Development · 510(k) 2026
- MiniMed Flex pumpMedtronic Minimed, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.